Statera Biopharma, Inc. Annual Depreciation in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Statera Biopharma, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2021.
  • Statera Biopharma, Inc. Depreciation for the quarter ending March 31, 2022 was $6.52K, a 723% increase year-over-year.
  • Statera Biopharma, Inc. annual Depreciation for 2021 was $22.5K, a 2271% increase from 2020.
  • Statera Biopharma, Inc. annual Depreciation for 2020 was $947.000.
  • Statera Biopharma, Inc. annual Depreciation for 2018 was $18.2K, a 13.8% decline from 2017.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $22.5K +$21.5K +2271% Jan 1, 2021 Dec 31, 2021 10-K 2022-10-06
2020 $947 Jan 1, 2020 Dec 31, 2020 10-K 2022-10-06
2018 $18.2K -$2.91K -13.8% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-07
2017 $21.1K -$42.4K -66.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $63.5K -$76.7K -54.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-06
2015 $140K -$60.7K -30.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-22
2014 $201K -$175K -46.6% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-23
2013 $376K -$103K -21.6% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-27
2012 $480K -$32.8K -6.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $512K +$123K +31.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $389K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.